{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:37:25Z","timestamp":1793047045450,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e0 degli Studi di Roma Tor Vergata","id":[{"id":"https:\/\/ror.org\/02p77k626","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40291-026-00871-4","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:59:47Z","timestamp":1786453187000},"page":"845-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-5496","authenticated-orcid":false,"given":"Luca","family":"Filippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Nuvoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Spanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"871_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1038614","volume":"15","author":"LD Cohen","year":"2022","unstructured":"Cohen LD, Ziv T, Ziv NE. Synapse integrity and function: dependence on protein synthesis and identification of potential failure points. Front Mol Neurosci. 2022;15:1038614. https:\/\/doi.org\/10.3389\/fnmol.2022.1038614.","journal-title":"Front Mol Neurosci"},{"key":"871_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.864514","volume":"16","author":"R Rossi","year":"2022","unstructured":"Rossi R, Arjmand S, B\u00e6rentzen SL, Gjedde A, Landau AM. Synaptic vesicle glycoprotein 2A: features and functions. Front Neurosci. 2022;16:864514. https:\/\/doi.org\/10.3389\/fnins.2022.864514.","journal-title":"Front Neurosci"},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1007\/s00330-025-11388-5","volume":"35","author":"A Bronte","year":"2025","unstructured":"Bronte A, Prieto E, Quincoces G, Erro E, Arbizu J. The basics of PET molecular imaging in neurodegenerative disorders with dementia and\/or parkinsonism. Eur Radiol. 2025;35:4621\u201334. https:\/\/doi.org\/10.1007\/s00330-025-11388-5.","journal-title":"Eur Radiol"},{"key":"871_CR4","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.24668.1","volume":"10","author":"T Wong","year":"2025","unstructured":"Wong T, Qiu Z, Notman B, Tavares A, Smith C, Grant SGN. SV2A is expressed in synapse subpopulations in mouse and human brain: implications for PET radiotracer studies. Wellcome Open Res. 2025;10:415. https:\/\/doi.org\/10.12688\/wellcomeopenres.24668.1.","journal-title":"Wellcome Open Res"},{"key":"871_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02816-9","volume":"148","author":"M Shanaki Bavarsad","year":"2024","unstructured":"Shanaki Bavarsad M, Spina S, Oehler A, Allen IE, Suemoto CK, Leite REP, et al. Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation. Acta Neuropathol. 2024;148:58. https:\/\/doi.org\/10.1007\/s00401-024-02816-9.","journal-title":"Acta Neuropathol"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.neuron.2018.07.007","volume":"99","author":"F Zhu","year":"2018","unstructured":"Zhu F, Cizeron M, Qiu Z, Benavides-Piccione R, Kopanitsa MV, Skene NG, et al. Architecture of the mouse brain synaptome. Neuron. 2018;99:781-799.e10. https:\/\/doi.org\/10.1016\/j.neuron.2018.07.007.","journal-title":"Neuron"},{"key":"871_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/epi.70122","author":"J Lang","year":"2026","unstructured":"Lang J, Linnerbauer M, Cuny J, rothhammer V, Hamer H. SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment response. Epilepsia. 2026. https:\/\/doi.org\/10.1002\/epi.70122.","journal-title":"Epilepsia"},{"key":"871_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11307-018-1260-5","volume":"21","author":"CC Constantinescu","year":"2019","unstructured":"Constantinescu CC, Tresse C, Zheng M, Gouasmat A, Carroll VM, Mistico L, et al. Development and in vivo preclinical imaging of fluorine-18-labeled synaptic vesicle protein 2A (SV2A) PET tracers. Mol Imaging Biol. 2019;21:509\u201318. https:\/\/doi.org\/10.1007\/s11307-018-1260-5.","journal-title":"Mol Imaging Biol"},{"key":"871_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2967\/jnumed.115.168179","volume":"57","author":"NB Nabulsi","year":"2016","unstructured":"Nabulsi NB, Mercier J, Holden D, Carr\u00e9 S, Najafzadeh S, Vandergeten M-C, et al. Synthesis and preclinical evaluation of 11C-UCB-J as a PET tracer for imaging the synaptic vesicle glycoprotein 2A in the brain. J Nucl Med. 2016;57:777\u201384. https:\/\/doi.org\/10.2967\/jnumed.115.168179.","journal-title":"J Nucl Med"},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1007\/s00259-025-07170-w","volume":"52","author":"L Berckmans","year":"2025","unstructured":"Berckmans L, Schrauwen C, Miranda A, Staelens S, Bertoglio D. Assessing non-invasive quantitative methods for [18F]SynVesT-1 PET imaging of synaptic vesicle glycoprotein 2A in the rat brain. Eur J Nucl Med Mol Imaging. 2025;52:3433\u201343. https:\/\/doi.org\/10.1007\/s00259-025-07170-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2967\/jnumed.120.249144","volume":"62","author":"M Naganawa","year":"2021","unstructured":"Naganawa M, Li S, Nabulsi N, Henry S, Zheng M-Q, Pracitto R, et al. First-in-human evaluation of 18F-SynVesT-1, a radioligand for PET imaging of synaptic vesicle glycoprotein 2A. J Nucl Med. 2021;62:561\u20137. https:\/\/doi.org\/10.2967\/jnumed.120.249144.","journal-title":"J Nucl Med"},{"key":"871_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1380561","volume":"16","author":"MS Bavarsad","year":"2024","unstructured":"Bavarsad MS, Grinberg LT. SV2A PET imaging in human neurodegenerative diseases. Front Aging Neurosci. 2024;16:1380561. https:\/\/doi.org\/10.3389\/fnagi.2024.1380561.","journal-title":"Front Aging Neurosci"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"60S","DOI":"10.2967\/jnumed.121.263201","volume":"63","author":"RE Carson","year":"2022","unstructured":"Carson RE, Naganawa M, Toyonaga T, Koohsari S, Yang Y, Chen M-K, et al. Imaging of synaptic density in neurodegenerative disorders. J Nucl Med. 2022;63:60S-67S. https:\/\/doi.org\/10.2967\/jnumed.121.263201.","journal-title":"J Nucl Med"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/alz.12582","volume":"18","author":"A Mecca","year":"2022","unstructured":"Mecca A, O\u2019Dell R, Sharp E, Banks E, Bartlett H, Zhao W, et al. Synaptic density and cognitive performance in Alzheimer\u2019s disease: a PET imaging study with [11C]UCB-J. Alzheimer\u2019s Dementia. 2022;18:2527\u201336. https:\/\/doi.org\/10.1002\/alz.12582.","journal-title":"Alzheimer\u2019s Dementia."},{"key":"871_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70344","volume":"21","author":"A Mecca","year":"2025","unstructured":"Mecca A, Ashton N, Chen M-K, O\u2019Dell R, Toyonaga T, Zhao W, et al. Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A: biomarkers of synaptic density in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2025;21:e70344. https:\/\/doi.org\/10.1002\/alz.70344.","journal-title":"Alzheimer\u2019s Dementia."},{"key":"871_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70403","volume":"21","author":"J Nilsson","year":"2025","unstructured":"Nilsson J, Mecca A, Ashton N, Salardini E, O\u2019Dell R, Carson R, et al. Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2025;21:e70403. https:\/\/doi.org\/10.1002\/alz.70403.","journal-title":"Alzheimer\u2019s Dementia."},{"key":"871_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","volume":"13","author":"R O\u2019Dell","year":"2021","unstructured":"O\u2019Dell R, Mecca A, Chen M-K, Naganawa M, Toyonaga T, Lu Y, et al. Association of A\u03b2 deposition and regional synaptic density in early Alzheimer\u2019s disease: a PET imaging study with [11C]UCB-J. Alzheimer\u2019s Res Ther. 2021;13:11. https:\/\/doi.org\/10.1186\/s13195-020-00742-y.","journal-title":"Alzheimer\u2019s Res Ther."},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/s41467-025-61497-4","volume":"16","author":"Y Luan","year":"2025","unstructured":"Luan Y, Wang W, Huang Q, Wang Y, Nussbaumer J, Wang J, et al. Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer\u2019s disease. Nat Commun. 2025;16:6356. https:\/\/doi.org\/10.1038\/s41467-025-61497-4.","journal-title":"Nat Commun"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"118248","DOI":"10.1016\/j.neuroimage.2021.118248","volume":"238","author":"Y Lu","year":"2021","unstructured":"Lu Y, Toyonaga T, Naganawa M, Gallezot J, Chen M-K, Mecca A, et al. Partial volume correction analysis for 11C-UCB-J PET studies of Alzheimer\u2019s disease. Neuroimage. 2021;238:118248\u2013118248. https:\/\/doi.org\/10.1016\/j.neuroimage.2021.118248.","journal-title":"Neuroimage"},{"key":"871_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13195-024-01382-2","volume":"16","author":"C Van Dyck","year":"2024","unstructured":"Van Dyck C, Mecca A, O\u2019Dell R, Bartlett H, Diepenbrock N, Huang Y, et al. A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2024;16:20. https:\/\/doi.org\/10.1186\/s13195-024-01382-2.","journal-title":"Alzheimer\u2019s Res Ther."},{"key":"871_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1177\/0271678X241230733","volume":"44","author":"J Li","year":"2024","unstructured":"Li J, Huang Q, Qi N, He K, Li S, Huang L, et al. The associations between synaptic density and \u201cA\/T\/N\u201d biomarkers in Alzheimer\u2019s disease: an 18F-SynVesT-1 PET\/MR study. J Cereb Blood Flow Metab. 2024;44:1199\u2013207. https:\/\/doi.org\/10.1177\/0271678X241230733.","journal-title":"J Cereb Blood Flow Metab"},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ana.26543","volume":"93","author":"M Malpetti","year":"2023","unstructured":"Malpetti M, Jones PS, Cope TE, Holland N, Naessens M, Rouse MA, et al. Synaptic loss in frontotemporal dementia revealed by [11 C]UCB-J positron emission tomography. Ann Neurol. 2023;93:142\u201354. https:\/\/doi.org\/10.1002\/ana.26543.","journal-title":"Ann Neurol"},{"key":"871_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P. Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord. 2024;122:106101. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106101.","journal-title":"Parkinsonism Relat Disord"},{"key":"871_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41531-024-00655-9","volume":"10","author":"S Holmes","year":"2024","unstructured":"Holmes S, Honhar P, Tinaz S, Naganawa M, Hilmer A, Gallezot J, et al. Synaptic loss and its association with symptom severity in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 2024;10:42. https:\/\/doi.org\/10.1038\/s41531-024-00655-9.","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"871_CR25","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1002\/mds.70041","volume":"40","author":"FE Sadabad","year":"2025","unstructured":"Sadabad FE, Volpi T, Honhar P, Tinaz S, Dias M, Toyonaga T, et al. Measuring dopamine transporter availability and synaptic density in Parkinson\u2019s disease: a dual\u2010tracer positron emission tomography imaging study. Mov Disord. 2025;40:2678\u201387. https:\/\/doi.org\/10.1002\/mds.70041.","journal-title":"Mov Disord"},{"key":"871_CR26","doi-asserted-by":"publisher","first-page":"fcaf258","DOI":"10.1093\/braincomms\/fcaf258","volume":"7","author":"SL Martin","year":"2025","unstructured":"Martin SL, Uribe C, Desmond KL, Narciso L, Dolman B, Torres-Carmona E, et al. [18F]SynVest-1 PET imaging in people with Parkinson\u2019s disease. Brain Commun. 2025;7:fcaf258. https:\/\/doi.org\/10.1093\/braincomms\/fcaf258.","journal-title":"Brain Commun"},{"key":"871_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mds.29375","volume":"38","author":"KB Andersen","year":"2023","unstructured":"Andersen KB, Hansen AK, Schacht AC, Horsager J, Gottrup H, Klit H, et al. Synaptic density and glucose consumption in patients with Lewy body diseases: an [11 C]UCB-J and [18 F]FDG PET study. Mov Disord. 2023;38:796\u2013805. https:\/\/doi.org\/10.1002\/mds.29375.","journal-title":"Mov Disord"},{"key":"871_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"D-EC Chung","year":"2021","unstructured":"Chung D-EC, Roemer S, Petrucelli L, Dickson DW. Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener. 2021;16:57. https:\/\/doi.org\/10.1186\/s13024-021-00476-x.","journal-title":"Mol Neurodegener"},{"key":"871_CR29","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/mds.29421","volume":"38","author":"N Holland","year":"2023","unstructured":"Holland N, Jones PS, Savulich G, Naessens M, Malpetti M, Whiteside DJ, et al. Longitudinal synaptic loss in primary tauopathies: an in vivo [11 C]UCB-J positron emission tomography study. Mov Disord. 2023;38:1316\u201326. https:\/\/doi.org\/10.1002\/mds.29421.","journal-title":"Mov Disord"},{"key":"871_CR30","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/mds.29814","volume":"39","author":"N Holland","year":"2024","unstructured":"Holland N, Savulich G, Jones PS, Whiteside DJ, Street D, Swann P, et al. Differential synaptic loss in \u03b2-amyloid positive versus \u03b2-amyloid negative corticobasal syndrome. Mov Disord. 2024;39:1166\u201378. https:\/\/doi.org\/10.1002\/mds.29814.","journal-title":"Mov Disord"},{"key":"871_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2026.108204","volume":"145","author":"X Hao","year":"2026","unstructured":"Hao X, Li Y, Wen Y, Zhou M, He Z, Jiao B, et al. Reduced synaptic density in patients with progressive supranuclear palsy: an 18F-SynVest-1 PET study. Parkinsonism Relat Disord. 2026;145:108204. https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108204.","journal-title":"Parkinsonism Relat Disord"},{"key":"871_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG. From pathogenesis to therapeutics: a review of 150 years of Huntington\u2019s disease research. Int J Mol Sci. 2023;24:13021. https:\/\/doi.org\/10.3390\/ijms241613021.","journal-title":"Int J Mol Sci"},{"key":"871_CR33","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/mds.29501","volume":"38","author":"A Delva","year":"2023","unstructured":"Delva A, Van Laere K, Vandenberghe W. Longitudinal imaging of regional brain volumes, SV2A, and glucose metabolism in Huntington\u2019s disease. Mov Disord. 2023;38:1515\u201326. https:\/\/doi.org\/10.1002\/mds.29501.","journal-title":"Mov Disord"},{"key":"871_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115240","volume":"26","author":"C Tolochko","year":"2025","unstructured":"Tolochko C, Shiryaeva O, Alekseeva T, Dyachuk V. Amyotrophic lateral sclerosis: pathophysiological mechanisms and treatment strategies (part 2). Int J Mol Sci. 2025;26:5240. https:\/\/doi.org\/10.3390\/ijms26115240.","journal-title":"Int J Mol Sci"},{"key":"871_CR35","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1111\/ene.15451","volume":"29","author":"Y Tang","year":"2022","unstructured":"Tang Y, Liu P, Li W, Liu Z, Zhou M, Li J, et al. Detection of changes in synaptic density in amyotrophic lateral sclerosis patients using 18 F-SynVesT-1 positron emission tomography. Eur J Neurol. 2022;29:2934\u201343. https:\/\/doi.org\/10.1111\/ene.15451.","journal-title":"Eur J Neurol"},{"key":"871_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107138","volume":"216","author":"ER de Natale","year":"2025","unstructured":"de Natale ER, Verghese JP, Terry A, Wilson H, Khosropanah P, Wright H, et al. An in vivo PET\/CT investigation of mitochondrial complex 1, sigma 1, and synaptic vesicle 2 A in patients with amyotrophic lateral sclerosis. Neurobiol Dis. 2025;216:107138. https:\/\/doi.org\/10.1016\/j.nbd.2025.107138.","journal-title":"Neurobiol Dis"},{"key":"871_CR37","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s00259-025-07612-5","volume":"53","author":"MS Azimi","year":"2026","unstructured":"Azimi MS, Rahmim A, Arabi H, Sanaat A, Zeraatkar N, Bouchareb Y, et al. Critical review of partial volume correction methods in PET and SPECT imaging: benefits, pitfalls, challenges, and future outlook. Eur J Nucl Med Mol Imaging. 2026;53:2830\u201361. https:\/\/doi.org\/10.1007\/s00259-025-07612-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"871_CR38","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834\u201340. https:\/\/doi.org\/10.1097\/00004647-199609000-00008.","journal-title":"J Cereb Blood Flow Metab"},{"key":"871_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X261454164","author":"G Vanderlinden","year":"2026","unstructured":"Vanderlinden G, Carron C, Van Opstal J, Cohilis M, Vandenberghe W, Koole M, et al. Quantification of 18F-SynVesT-1 binding in healthy ageing and head-to-head comparison with 11C-UCB-J. J Cereb Blood Flow Metab. 2026. https:\/\/doi.org\/10.1177\/0271678X261454164.","journal-title":"J Cereb Blood Flow Metab"},{"key":"871_CR40","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/jcbfm.2013.26","volume":"33","author":"F Zanderigo","year":"2013","unstructured":"Zanderigo F, Ogden RT, Parsey RV. Reference region approaches in PET: a comparative study on multiple radioligands. J Cereb Blood Flow Metab. 2013;33:888\u201397. https:\/\/doi.org\/10.1038\/jcbfm.2013.26.","journal-title":"J Cereb Blood Flow Metab"},{"key":"871_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-024-01224-5","volume":"24","author":"G Vanderlinden","year":"2024","unstructured":"Vanderlinden G, Carron C, Vandenberghe R, Vandenbulcke M, Van Laere K. In vivo PET of synaptic density as potential diagnostic marker for cognitive disorders: prospective comparison with current imaging markers for neuronal dysfunction and relation to symptomatology\u2014study protocol. BMC Med Imaging. 2024;24:41. https:\/\/doi.org\/10.1186\/s12880-024-01224-5.","journal-title":"BMC Med Imaging"},{"key":"871_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s13139-025-00932-2","volume":"59","author":"Y Bouter","year":"2025","unstructured":"Bouter Y, Glasnek RM, Wenzel JM, Bouter C. 18F-FDG-PET and multimodal biomarker integration: a powerful tool for Alzheimer\u2019s disease diagnosis. Nucl Med Mol Imaging. 2025;59:453\u201371. https:\/\/doi.org\/10.1007\/s13139-025-00932-2.","journal-title":"Nucl Med Mol Imaging"},{"key":"871_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s41824-024-00232-6","volume":"9","author":"PM Tuan","year":"2025","unstructured":"Tuan PM, Adel M, Trung NL, Horowitz T, Parlak IB, Guedj E. FDG-PET-based brain network analysis: a brief review of metabolic connectivity. EJNMMI Rep. 2025;9:4. https:\/\/doi.org\/10.1186\/s41824-024-00232-6.","journal-title":"EJNMMI Rep"},{"key":"871_CR44","doi-asserted-by":"publisher","first-page":"W76","DOI":"10.2214\/AJR.13.12363","volume":"204","author":"VKN Shivamurthy","year":"2015","unstructured":"Shivamurthy VKN, Tahari AK, Marcus C, Subramaniam RM. Brain FDG PET and the diagnosis of dementia. AJR Am J Roentgenol. 2015;204:W76-85. https:\/\/doi.org\/10.2214\/AJR.13.12363.","journal-title":"AJR Am J Roentgenol"},{"key":"871_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-01164-z","volume":"11","author":"G Palermo","year":"2025","unstructured":"Palermo G, Aghakhanyan G, Bellini G, Giannoni S, Vadi G, Francischello R, et al. Discriminating between proposed brain-first and body-first Parkinson\u2019s disease using conventional and radiomics-enhanced dopamine transporter SPECT image analysis. NPJ Parkinsons Dis. 2025;11:328. https:\/\/doi.org\/10.1038\/s41531-025-01164-z.","journal-title":"NPJ Parkinsons Dis"},{"key":"871_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2026.2636657","author":"V Frantellizzi","year":"2026","unstructured":"Frantellizzi V, Cambieri C, Galosi E, Chimenti C, Marchionni G, Alfarano M, et al. Early cardiac sympathetic denervation in hereditary transthyretin amyloidosis: 123I-metaiodobenzylguanidine\u00a0findings and correlation with skin biopsy. Amyloid. 2026. https:\/\/doi.org\/10.1080\/13506129.2026.2636657.","journal-title":"Amyloid"},{"key":"871_CR47","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1007\/s00259-025-07729-7","volume":"53","author":"L Filippi","year":"2026","unstructured":"Filippi L, Bianconi F, Frantellizzi V, Ferrari C, Marongiu A, De Feo MS, et al. Machine learning for automated differentiation of parkinson\u2019s disease and its mimics using 123I-mIBG scintigraphy: insights from a multicentre real-world cohort (ITA-mIBG study). Eur J Nucl Med Mol Imaging. 2026;53:3469\u201380. https:\/\/doi.org\/10.1007\/s00259-025-07729-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"871_CR48","doi-asserted-by":"publisher","first-page":"e70296","DOI":"10.1002\/dad2.70296","volume":"18","author":"PC Donaghy","year":"2026","unstructured":"Donaghy PC, Greenfinch G, Petrides G, Kane J, Verberne HJ, Taylor J-P, et al. Delphi consensus guidelines for the use of striatal dopaminergic imaging and cardiac metaiodobenzylguanidine (MIBG) scintigraphy for the diagnosis of dementia and mild cognitive impairment with Lewy bodies. Alzheimers Dement (Amst). 2026;18:e70296. https:\/\/doi.org\/10.1002\/dad2.70296.","journal-title":"Alzheimers Dement (Amst)."},{"key":"871_CR49","doi-asserted-by":"publisher","first-page":"17689","DOI":"10.1039\/d5cc05507e","volume":"61","author":"M Qin","year":"2025","unstructured":"Qin M, Mishra P, Hind J, Fallis IA, Tredwell M. The synthesis of [18F]SynVesT-1 and [18F]SynVesT-2 from enantioenriched boronic esters. Chem Commun (Camb). 2025;61:17689\u201392. https:\/\/doi.org\/10.1039\/d5cc05507e.","journal-title":"Chem Commun (Camb)"},{"key":"871_CR50","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.271207","author":"N Hern\u00e1ndez-Mart\u00edn","year":"2026","unstructured":"Hern\u00e1ndez-Mart\u00edn N, Balayeva T, Naganawa M, Asch RH, Huang Y, Carson RE, et al. Noninvasive quantification of [18F]SynVesT-2 PET in healthy human brains using simplified reference tissue models. J Nucl Med. 2026. https:\/\/doi.org\/10.2967\/jnumed.125.271207.","journal-title":"J Nucl Med"},{"key":"871_CR51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/17434440.2025.2522822","volume":"22","author":"L Filippi","year":"2025","unstructured":"Filippi L, Danieli R. Unlocking the brain\u2019s secrets: the NeuroEXPLORER revolution in PET imaging. Expert Rev Med Devices. 2025;22:783\u20136. https:\/\/doi.org\/10.1080\/17434440.2025.2522822.","journal-title":"Expert Rev Med Devices"},{"key":"871_CR52","doi-asserted-by":"publisher","DOI":"10.1109\/trpms.2025.3638588","author":"C Lo","year":"2025","unstructured":"Lo C, Shanina E, Gravel P, Hu Y, Lucero SA, Martins S, et al. Development and initial evaluation of 3D-printed high resolution brain phantom for PET. IEEE Trans Radiat Plasma Med Sci. 2025. https:\/\/doi.org\/10.1109\/trpms.2025.3638588.","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"871_CR53","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X261429044","author":"S Mehta","year":"2026","unstructured":"Mehta S, Sun H, Micali N, Holden D, Fowles K, Rossano S, et al. High-resolution in utero SV2A PET imaging of the nonhuman primate brain using the NeuroEXPLORER. J Cereb Blood Flow Metab. 2026. https:\/\/doi.org\/10.1177\/0271678X261429044.","journal-title":"J Cereb Blood Flow Metab"},{"key":"871_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40336-020-00404-x","volume":"9","author":"B Palumbo","year":"2021","unstructured":"Palumbo B, Bianconi F, Nuvoli S, Spanu A, Fravolini ML. Artificial intelligence techniques support nuclear medicine modalities to improve the diagnosis of Parkinson\u2019s disease and Parkinsonian syndromes. Clin Transl Imaging. 2021;9:19\u201335. https:\/\/doi.org\/10.1007\/s40336-020-00404-x.","journal-title":"Clin Transl Imaging"},{"key":"871_CR55","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejmp.2021.03.008","volume":"83","author":"H Arabi","year":"2021","unstructured":"Arabi H, AkhavanAllaf A, Sanaat A, Shiri I, Zaidi H. The promise of artificial intelligence and deep learning in PET and SPECT imaging. Phys Med AIFB. 2021;83:122\u201337. https:\/\/doi.org\/10.1016\/j.ejmp.2021.03.008.","journal-title":"Phys Med. AIFB"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00871-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00871-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00871-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:01:52Z","timestamp":1793044912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00871-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1007\/s40291-026-00871-4","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was partially supported by funding from the Italian Ministry of Health (Ricerca Corrente).","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors (L.F., S.N., A.S., and B.P.) have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent (participation and publication)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed.","order":4,"name":"Ethics","label":"Availability of data and material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Code availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Luca Filippi and Barbara Palumbo: conceptualization, writing of the first draft and revision; Susanna Nuvoli, Luca Filippi, and Barbara Palumbo: collection and interpretation of data; Angela Spanu: revision of the first draft and supervision. All the authors have read and approved the final version of the manuscript.","order":6,"name":"Ethics","label":"Author contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}